Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO

Stock Track

04/18

Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.

The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.

Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1176686851"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176686851\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176686851?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-18 00:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176686851","market":"nz","top_or_hot":-1,"title":"Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO","media":"Stock Track","content":"<p>Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.</p><p>The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.</p><p>Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-18 00:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.</p><p>The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.</p><p>Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALMR","symbol_name":"Alamar Biosciences, Inc.","start_time":0,"source_url":"","article_id":"1176686851","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176686851","pubTimestamp":1776443855,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.The proteomics company, which develops instruments to detect...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALMR":"Alamar Biosciences, Inc."},"translate_title":"个股赛道|Alamar Biosciences在扩大IPO规模后在纳斯达克首次亮相表现强劲，盘中飙升32.94%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALMR":1},"content_text":"Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}